Relmada Therapeutics, Inc. Common Stock (NASDAQ: RLMD) last traded at $3.39, up 6.94% on the session. The quote above updates while this page is open; the figures below are drawn from Relmada Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Relmada Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RLMD. Its market capitalisation is $361.61 million.
Valuation measures for Relmada Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $361.61M |
|---|---|
| Enterprise value | $362.78M |
| Price / book | 1.75 |
| Beta | 1.66 |
Trailing-twelve-month figures tagged in Relmada Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$61.93M |
| Return on equity | -29.98% |
|---|
| Cash | $11.33M |
|---|
Range and volume for RLMD over the past 52 weeks.
| 52-week high | $8.00 |
|---|---|
| 52-week low | $1.80 |
| Volume | 1.73M |
| Average volume | 1.34M |
| Previous close | $3.17 |
Invest a chosen dollar amount in Relmada Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RLMD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.